KEGG   Ochotona princeps (American pika): 101522490
Entry
101522490         CDS       T07609                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
opi  Ochotona princeps (American pika)
Pathway
opi01522  Endocrine resistance
opi01524  Platinum drug resistance
opi04012  ErbB signaling pathway
opi04066  HIF-1 signaling pathway
opi04068  FoxO signaling pathway
opi04110  Cell cycle
opi04115  p53 signaling pathway
opi04151  PI3K-Akt signaling pathway
opi04218  Cellular senescence
opi04630  JAK-STAT signaling pathway
opi04921  Oxytocin signaling pathway
opi04928  Parathyroid hormone synthesis, secretion and action
opi04934  Cushing syndrome
opi05160  Hepatitis C
opi05161  Hepatitis B
opi05163  Human cytomegalovirus infection
opi05165  Human papillomavirus infection
opi05166  Human T-cell leukemia virus 1 infection
opi05167  Kaposi sarcoma-associated herpesvirus infection
opi05169  Epstein-Barr virus infection
opi05200  Pathways in cancer
opi05202  Transcriptional misregulation in cancer
opi05203  Viral carcinogenesis
opi05205  Proteoglycans in cancer
opi05206  MicroRNAs in cancer
opi05210  Colorectal cancer
opi05211  Renal cell carcinoma
opi05212  Pancreatic cancer
opi05213  Endometrial cancer
opi05214  Glioma
opi05215  Prostate cancer
opi05216  Thyroid cancer
opi05217  Basal cell carcinoma
opi05218  Melanoma
opi05219  Bladder cancer
opi05220  Chronic myeloid leukemia
opi05222  Small cell lung cancer
opi05223  Non-small cell lung cancer
opi05224  Breast cancer
opi05225  Hepatocellular carcinoma
opi05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:opi00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    101522490 (CDKN1A)
   04630 JAK-STAT signaling pathway
    101522490 (CDKN1A)
   04066 HIF-1 signaling pathway
    101522490 (CDKN1A)
   04068 FoxO signaling pathway
    101522490 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    101522490 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    101522490 (CDKN1A)
   04115 p53 signaling pathway
    101522490 (CDKN1A)
   04218 Cellular senescence
    101522490 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    101522490 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    101522490 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    101522490 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    101522490 (CDKN1A)
   05206 MicroRNAs in cancer
    101522490 (CDKN1A)
   05205 Proteoglycans in cancer
    101522490 (CDKN1A)
   05203 Viral carcinogenesis
    101522490 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    101522490 (CDKN1A)
   05212 Pancreatic cancer
    101522490 (CDKN1A)
   05225 Hepatocellular carcinoma
    101522490 (CDKN1A)
   05226 Gastric cancer
    101522490 (CDKN1A)
   05214 Glioma
    101522490 (CDKN1A)
   05216 Thyroid cancer
    101522490 (CDKN1A)
   05220 Chronic myeloid leukemia
    101522490 (CDKN1A)
   05217 Basal cell carcinoma
    101522490 (CDKN1A)
   05218 Melanoma
    101522490 (CDKN1A)
   05211 Renal cell carcinoma
    101522490 (CDKN1A)
   05219 Bladder cancer
    101522490 (CDKN1A)
   05215 Prostate cancer
    101522490 (CDKN1A)
   05213 Endometrial cancer
    101522490 (CDKN1A)
   05224 Breast cancer
    101522490 (CDKN1A)
   05222 Small cell lung cancer
    101522490 (CDKN1A)
   05223 Non-small cell lung cancer
    101522490 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    101522490 (CDKN1A)
   05161 Hepatitis B
    101522490 (CDKN1A)
   05160 Hepatitis C
    101522490 (CDKN1A)
   05163 Human cytomegalovirus infection
    101522490 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    101522490 (CDKN1A)
   05169 Epstein-Barr virus infection
    101522490 (CDKN1A)
   05165 Human papillomavirus infection
    101522490 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    101522490 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    101522490 (CDKN1A)
   01522 Endocrine resistance
    101522490 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 101522490
NCBI-ProteinID: XP_012783951
LinkDB
Position
12:34521729..34527100
AA seq 286 aa
MAPADKPRLRLRGGGRVLPQHARLRPAALLELSQAPAARRGPGAGTAGHGGGCGSETMRP
GRARTFRGRGGAVARWRGRDFRAVPAQRDVFAARAPPALPAPSDARPQWKRNAGGRERST
MPQLSSSDEMPQSPRRSKACRRLFGPVDSEQLRRDCDALMAGCLQEARERWNFDFVTETP
LEGNFAWERVRGLGLPKLYLSPGSQNGHDDLGGGKLPGPSAVLLPGSAREDHLALSLSCT
LVPHSPERPEDSPGAPGSSQGRKRRQTSMTDFYLSKRRLVFSRRKP
NT seq 861 nt   +upstreamnt  +downstreamnt
atggctccggcagacaaacccaggctacggctgcggggaggagggcgcgtcctcccgcag
cacgcgaggctccggccggccgccctgctggagctcagccaggctccagcagccagaagg
ggcccgggcgcgggcacggccggccacggcggcggctgcggtagcgagacgatgcgcccg
gggcgagcgcgcactttccgtggccgcggtggcgcggtggcgcggtggcgcgggcgggac
tttcgggctgtgccggctcagcgtgacgtgttcgcggcgcgggctcctcctgctctcccc
gccccgagtgacgcgcggccgcagtggaagcgcaatgccggcgggcgggagcgcagcacc
atgccgcagctgtcatcgtctgatgaaatgccacagtccccccgccggagcaaggcctgc
cgccgcctcttcggccccgtggacagcgagcagctgcgccgtgactgtgacgcactgatg
gccggctgcctgcaggaagcccgggagcgatggaacttcgactttgtcaccgagacgcca
ctggagggcaactttgcctgggagcgtgtgcggggcctgggcctgcccaagctttacctg
tccccagggtcccagaatggccacgatgacctgggagggggtaagctgcctggcccctca
gcggtcctgctgccgggctcagctcgggaggatcacctggccctgtcgctgtcctgcacc
ctcgtgcctcactcccctgagcggcccgaggattccccaggtgcgcctggcagctctcag
ggacgaaaacggcggcagaccagcatgacagatttctacctctccaaacgccggctcgtc
ttctcccggaggaagccctga

DBGET integrated database retrieval system